451 related articles for article (PubMed ID: 9820486)
1. Acceleration of lpr lymphoproliferative and autoimmune disease by transgenic protein kinase CK2 alpha.
Rifkin IR; Channavajhala PL; Kiefer HL; Carmack AJ; Landesman-Bollag E; Beaudette BC; Jersky B; Salant DJ; Ju ST; Marshak-Rothstein A; Seldin DC
J Immunol; 1998 Nov; 161(10):5164-70. PubMed ID: 9820486
[TBL] [Abstract][Full Text] [Related]
2. Origin of CD4-CD8-B220+ T cells in MRL-lpr/lpr mice. Clues from a T cell receptor beta transgenic mouse.
Zhou T; Bluethmann H; Eldridge J; Berry K; Mountz JD
J Immunol; 1993 Apr; 150(8 Pt 1):3651-67. PubMed ID: 7682246
[TBL] [Abstract][Full Text] [Related]
3. Expression in transgenic mice of dominant interfering Fas mutations: a model for human autoimmune lymphoproliferative syndrome.
Choi Y; Ramnath VR; Eaton AS; Chen A; Simon-Stoos KL; Kleiner DE; Erikson J; Puck JM
Clin Immunol; 1999 Oct; 93(1):34-45. PubMed ID: 10497009
[TBL] [Abstract][Full Text] [Related]
4. The proliferative in vivo activities of lpr double-negative T cells and the primary role of p59fyn in their activation and expansion.
Balomenos D; Rumold R; Theofilopoulos AN
J Immunol; 1997 Sep; 159(5):2265-73. PubMed ID: 9278315
[TBL] [Abstract][Full Text] [Related]
5. Intestinal intraepithelial lymphocyte T cells are resistant to lpr gene-induced T cell abnormalities.
Aicher WK; Fujihashi K; Taguchi T; McGhee JR; Yamamoto M; Eldridge JH; Gay S; Kiyono H
Eur J Immunol; 1992 Jan; 22(1):137-45. PubMed ID: 1346108
[TBL] [Abstract][Full Text] [Related]
6. In CD8+ T cell-deficient lpr/lpr mice, CD4+B220+ and CD4+B220- T cells replace B220+ double-negative T cells as the predominant populations in enlarged lymph nodes.
Giese T; Davidson WF
J Immunol; 1995 May; 154(10):4986-95. PubMed ID: 7537297
[TBL] [Abstract][Full Text] [Related]
7. CD2-CD4-CD8- lymph node T lymphocytes in MRL lpr/lpr mice are derived from a CD2+CD4+CD8+ thymic precursor.
Landolfi MM; Van Houten N; Russell JQ; Scollay R; Parnes JR; Budd RC
J Immunol; 1993 Jul; 151(2):1086-96. PubMed ID: 7687614
[TBL] [Abstract][Full Text] [Related]
8. Transgenic expression of Fas in T cells blocks lymphoproliferation but not autoimmune disease in MRL-lpr mice.
Fukuyama H; Adachi M; Suematsu S; Miwa K; Suda T; Yoshida N; Nagata S
J Immunol; 1998 Apr; 160(8):3805-11. PubMed ID: 9558084
[TBL] [Abstract][Full Text] [Related]
9. Chronic treatment of C3H-lpr/lpr and C3H-gld/gld mice with anti-CD8 monoclonal antibody prevents the accumulation of double negative T cells but not autoantibody production.
Giese T; Davidson WF
J Immunol; 1994 Feb; 152(4):2000-10. PubMed ID: 8120404
[TBL] [Abstract][Full Text] [Related]
10. TcR-alpha/beta(+) CD4(-)CD8(-) T cells in humans with the autoimmune lymphoproliferative syndrome express a novel CD45 isoform that is analogous to murine B220 and represents a marker of altered O-glycan biosynthesis.
Bleesing JJ; Brown MR; Dale JK; Straus SE; Lenardo MJ; Puck JM; Atkinson TP; Fleisher TA
Clin Immunol; 2001 Sep; 100(3):314-24. PubMed ID: 11513545
[TBL] [Abstract][Full Text] [Related]
11. Repeated 0.5-Gy gamma irradiation attenuates autoimmune disease in MRL-lpr/lpr mice with suppression of CD3+CD4-CD8-B220+ T-cell proliferation and with up-regulation of CD4+CD25+Foxp3+ regulatory T cells.
Tago F; Tsukimoto M; Nakatsukasa H; Kojima S
Radiat Res; 2008 Jan; 169(1):59-66. PubMed ID: 18159952
[TBL] [Abstract][Full Text] [Related]
12. Evidence for early onset, polyclonal activation of T cell subsets in mice homozygous for lpr.
Giese T; Davidson WF
J Immunol; 1992 Nov; 149(9):3097-106. PubMed ID: 1383337
[TBL] [Abstract][Full Text] [Related]
13. IFN-gamma receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Fas(lpr) mice.
Schwarting A; Wada T; Kinoshita K; Tesch G; Kelley VR
J Immunol; 1998 Jul; 161(1):494-503. PubMed ID: 9647261
[TBL] [Abstract][Full Text] [Related]
14. Suppression of autoimmune disease and of massive lymphadenopathy in MRL/Mp-lpr/lpr mice lacking tyrosine kinase Fyn (p59fyn).
Takahashi T; Yagi T; Kakinuma S; Kurokawa A; Okada T; Takatsu K; Aizawa S; Katagiri T
J Immunol; 1997 Sep; 159(5):2532-41. PubMed ID: 9278347
[TBL] [Abstract][Full Text] [Related]
15. Evidence for the existence of two parallel differentiation pathways in the thymus of MRL lpr/lpr mice.
Matsuzaki Y; Pannetien C; Kanagawa O; Gachelin G; Nakauchi H
J Immunol; 1992 Aug; 149(3):1069-74. PubMed ID: 1378863
[TBL] [Abstract][Full Text] [Related]
16. Selection of the T cell receptor repertoire in Lpr mice.
Herron LR; Eisenberg RA; Roper E; Kakkanaiah VN; Cohen PL; Kotzin BL
J Immunol; 1993 Oct; 151(7):3450-9. PubMed ID: 8376785
[TBL] [Abstract][Full Text] [Related]
17. Elevated production of interferon-gamma and interleukin 4 by mature T cells from autoimmune lpr mice correlates with Pgp-1 (CD44) expression.
Budd RC; Schumacher JH; Winslow G; Mosmann TR
Eur J Immunol; 1991 Apr; 21(4):1081-4. PubMed ID: 1902176
[TBL] [Abstract][Full Text] [Related]
18. Functional distinctions between MRL-lpr and MRL-gld lymphocytes. Normal cells reverse the gld but not lpr immunoregulatory defect.
Ettinger R; Wang JK; Bossu P; Papas K; Sidman CL; Abbas AK; Marshak-Rothstein A
J Immunol; 1994 Feb; 152(4):1557-68. PubMed ID: 8120369
[TBL] [Abstract][Full Text] [Related]
19. Decreased CD4-CD8- TCR-alpha beta + cells in lpr/lpr mice lacking beta 2-microglobulin.
Mixter PF; Russell JQ; Durie FH; Budd RC
J Immunol; 1995 Mar; 154(5):2063-74. PubMed ID: 7868883
[TBL] [Abstract][Full Text] [Related]
20. Clear suppression of Th1 responses but marginal amelioration of autoimmune manifestations by IL-12p40 transgene in MRL-FAS(lprcg)/FAS(lprcg) mice.
Yasuda T; Yoshimoto T; Tsubura A; Matsuzawa A
Cell Immunol; 2001 Jun; 210(2):77-86. PubMed ID: 11520074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
